195
Views
45
CrossRef citations to date
0
Altmetric
Review

Biomarker discovery using protein microarray technology platforms: antibody-antigen complex profiling

, , &
Pages 879-889 | Published online: 09 Jan 2014

References

  • Watson JD. The human genome project: past, present, and future. Science 248(4951), 44–49 (1990).
  • Nishizuka S, Chen ST, Gwadry FG et al. Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling. Cancer Res. 63(17), 5243–5250 (2003).
  • Diamandis EP. Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol. Cell. Proteomics 3(4), 367–378 (2004).
  • Silzel JW, Cercek B, Dodson C, Tsay T, Obremski RJ. Mass-sensing, multianalyte microarray immunoassay with imaging detection. Clin. Chem. 44(9), 2036–2043 (1998).
  • Disis ML, Montgomery RB, Goodell V, de la Rosa C, Salazar LG. Antibody immunity to cancer-associated proteins. AACR 96th Annual Meeting, April 16–20, CA, USA, 166–169 (2005).
  • Fossa A, Berner A, Fossa SD et al. NY-ESO-1 protein expression and humoral immune responses in prostate cancer. Prostate 59(4), 440–447 (2004).
  • van Rhee F, Szmania SM, Zhan F et al. NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses. Blood 105(10), 3939–3944 (2005).
  • Ermann J, Fathman CG. Autoimmune diseases: genes, bugs and failed regulation. Nature Immunol. 2(9), 759–761 (2001).
  • Arbuckle MR, McClain MT, Rubertone MV et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 349(16), 1526–1533 (2003).
  • Kallioniemi OP, Wagner U, Kononen J, Sauter G. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum. Mol. Genet. 10(7), 657–662 (2001).
  • Kononen J, Bubendorf L, Kallioniemi A et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nature Med. 4(7), 844–847 (1998).
  • Berger AJ, Kluger HM, Li N et al. Subcellular localization of activating transcription factor 2 in melanoma specimens predicts patient survival. Cancer Res. 63(23), 8103–8107 (2003).
  • Camp RL, Dolled-Filhart M, King BL, Rimm DL. Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome. Cancer Res. 63(7), 1445–1448 (2003).
  • Kluger HM, Dolled-Filhart M, Rodov S et al. Macrophage colony-stimulating factor-1 receptor expression is associated with poor outcome in breast cancer by large cohort tissue microarray analysis. Clin. Cancer Res. 10(1 Pt 1), 173–177 (2004).
  • Rubin MA, Zerkowski MP, Camp RL et al. Quantitative determination of expression of the prostate cancer protein α-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurements. Am. J. Pathol. 164(3), 831–840 (2004).
  • Perrone EE, Theoharis C, Mucci NR et al. Tissue microarray assessment of prostate cancer tumor proliferation in African–American and white men. J. Natl Cancer Inst. 92(11), 937–939 (2000).
  • Rubin MA, Dunn R, Strawderman M, Pienta KJ. Tissue microarray sampling strategy for prostate cancer biomarker analysis. Am. J. Surg. Pathol. 26(3), 312–319 (2002).
  • Uhlen M, Ponten F. Antibody-based proteomics for human tissue profiling. Mol. Cell. Proteomics 4(4), 384–393 (2005).
  • Ziauddin J, Sabatini DM. Microarrays of cells expressing defined cDNAs. Nature 411(6833), 107–110 (2001).
  • Conrad C, Erfle H, Warnat P et al. Automatic identification of subcellular phenotypes on human cell arrays. Genome Res. 14(6), 1130–1136 (2004).
  • Vanhecke D, Janitz M. High-throughput gene silencing using cell arrays. Oncogene 23(51), 8353–8358 (2004).
  • Silva JM, Mizuno H, Brady A, Lucito R, Hannon GJ. RNA interference microarrays: high-throughput loss-of-function genetics in mammalian cells. Proc. Natl Acad. Sci. USA 101(17), 6548–6552 (2004).
  • Espina V, Mehta AI, Winters ME et al. Protein microarrays: molecular profiling technologies for clinical specimens. Proteomics 3(11), 2091–2100 (2003).
  • Chan SM, Ermann J, Su L, Fathman CG, Utz PJ. Protein microarrays for multiplex analysis of signal transduction pathways. Nature Med. 10(12), 1390–1396 (2004).
  • Nam MJ, Madoz-Gurpide J, Wang H et al. Molecular profiling of the immune response in colon cancer using protein microarrays: occurrence of autoantibodies to ubiquitin C-terminal hydrolase L3. Proteomics 3(11), 2108–2115 (2003).
  • Potgens AJ, Schmitz U, Kaufmann P, Frank HG. Monoclonal antibody CD133–2 (AC141) against hematopoietic stem cell antigen CD133 shows crossreactivity with cytokeratin 18. J. Histochem. Cytochem. 50(8), 1131–1134 (2002).
  • Hoglund AS, Jones AM, Josefsson LG. An antigen expressed during plant vascular development crossreacts with antibodies towards KLH (keyhole limpet hemocyanin). J. Histochem. Cytochem. 50(8), 999–1003 (2002).
  • Fouraux MA, van der Heijden A, van Venrooij WJ, Pruijn GJ. Cross-reactivity of the antiLa monoclonal antibody SW5 with early endosome antigen 2. Immunology 106(3), 336–342 (2002).
  • Predki PF, Mattoon D, Bangham R, Schweitzer B, Michaud G. Protein microarrays: a new tool for profiling antibody cross-reactivity. Hum. Antibodies 14(1) (2005).
  • Michaud GA, Salcius M, Zhou F et al. Analyzing antibody specificity with whole proteome microarrays. Nature Biotechnol. 21(12), 1509–1512 (2003).
  • Robinson WH, DiGennaro C, Hueber W et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nature Med. 8(3), 295–301 (2002).
  • Wang D, Liu S, Trummer BJ, Deng C, Wang A. Carbohydrate microarrays for the recognition of cross-reactive molecular markers of microbes and host cells. Nature Biotechnol. 20(3), 275–281 (2002).
  • Zhu H, Bilgin M, Bangham R et al. Global analysis of protein activities using proteome chips. Science 293(5537), 2101–2105 (2001).
  • Lueking A, Possling A, Huber O et al. A nonredundant human protein chip for antibody screening and serum profiling. Mol. Cell. Proteomics 2(12), 1342–1349 (2003).
  • Soen Y, Chen DS, Kraft DL, Davis MM, Brown PO. Detection and characterization of cellular immune responses using peptide–MHC microarrays. PLoS Biol. 1(3), e65 (2003).
  • Moody MD, Van Arsdell SW, Murphy KP, Orencole SF, Burns C. Array-based ELISAs for high-throughput analysis of human cytokines. Biotechniques 31(1), 186–190, 192–184 (2001).
  • Huang RP, Huang R, Fan Y, Lin Y. Simultaneous detection of multiple cytokines from conditioned media and patient’s sera by an antibody-based protein array system. Anal. Biochem. 294(1), 55–62 (2001).
  • Tam SW, Wiese R, Lee S, Gilmore J, Kumble KD. Simultaneous analysis of eight human Th1/Th2 cytokines using microarrays. J. Immunol. Methods 261(1–2), 157–165 (2002).
  • Wiese R, Belosludtsev Y, Powdrill T, Thompson P, Hogan M. Simultaneous multianalyte ELISA performed on a microarray platform. Clin. Chem. 47(8), 1451–1457 (2001).
  • Jenison R, La H, Haeberli A, Ostroff R, Polisky B. Silicon-based biosensors for rapid detection of protein or nucleic acid targets. Clin. Chem. 47(10), 1894–1900 (2001).
  • Schweitzer B, Roberts S, Grimwade B et al. Multiplexed protein profiling on microarrays by rolling-circle amplification. Nature Biotechnol. 20(4), 359–365 (2002).
  • MacBeath G. Protein microarrays and proteomics. Nature Genet. 32(Suppl.), 526–532 (2002).
  • Nielsen UB, Cardone MH, Sinskey AJ, MacBeath G, Sorger PK. Profiling receptor tyrosine kinase activation by using Ab microarrays. Proc. Natl Acad. Sci. USA 100(16), 9330–9335 (2003).
  • Dax EM, Arnott A. Advances in laboratory testing for HIV. Pathology 36(6), 551–560 (2004).
  • Mezzasoma L, Bacarese-Hamilton T, Di Cristina M et al. Antigen microarrays for serodiagnosis of infectious diseases. Clin. Chem. 48(1), 121–130 (2002).
  • Arnaud MC, Gazarian T, Rodriguez YP, Gazarian K, Sakanyan V. Array assessment of phage-displayed peptide mimics of human immunodeficiency virus Type 1 gp41 immunodominant epitope: binding to antibodies of infected individuals. Proteomics 4(7), 1959–1964 (2004).
  • Steller S, Angenendt P, Cahill DJ et al. Bacterial protein microarrays for identification of new potential diagnostic markers for Neisseria meningitidis infections. Proteomics 5(8), 2048–2055 (2005).
  • Davies DH, Liang X, Hernandez JE et al. Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc. Natl Acad. Sci. USA 102(3), 547–552 (2005).
  • Wiltshire S, O’Malley S, Lambert J et al. Detection of multiple allergen-specific IgEs on microarrays by immunoassay with rolling circle amplification. Clin. Chem. 46(12), 1990–1993 (2000).
  • Hiller R, Laffer S, Harwanegg C et al. Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J. 16(3), 414–416 (2002).
  • Alcocer MJ, Murtagh GJ, Wilson PB et al. The major human structural IgE epitope of the Brazil nut allergen Ber e 1: a chimaeric and protein microarray approach. J. Mol. Biol. 343(3), 759–769 (2004).
  • Fathman CG, Soares L, Chan SM, Utz PJ. An array of possibilities for the study of autoimmunity. Nature 435(7042), 605–611 (2005).
  • Robinson WH, Fontoura P, Lee BJ et al. Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis. Nature Biotechnol. 21(9), 1033–1039 (2003).
  • Quintana FJ, Hagedorn PH, Elizur G et al. Functional immunomics: microarray analysis of IgG autoantibody repertoires predicts the future response of mice to induced diabetes. Proc. Natl Acad. Sci. USA, 101(Suppl. 2), 14615–14621 (2004).
  • Braun P, Hu Y, Shen B et al. Proteome-scale purification of human proteins from bacteria. Proc. Natl Acad. Sci. USA 99(5), 2654–2659 (2002).
  • Lueking A, Huber O, Wirths C et al. Profiling of alopecia areata autoantigens based on protein microarray technology. Mol. Cell. Proteomics 4(9), 1382–1390 (2005).
  • Gutjahr C, Murphy D, Lueking A et al. Mouse protein arrays from a TH1 cell cDNA library for antibody screening and serum profiling. Genomics 85(3), 285–296 (2005).
  • Chen G, Gharib TG, Wang H et al. Protein profiles associated with survival in lung adenocarcinoma. Proc. Natl Acad. Sci. USA 100(23), 13537–13542 (2003).
  • Brichory FM, Misek DE, Yim AM et al. An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc. Natl Acad. Sci. USA 98(17), 9824–9829 (2001).
  • Le Naour F, Brichory F, Misek DE et al. A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis. Mol. Cell. Proteomics 1(3), 197–203 (2002).
  • Shin BK, Wang H, Yim AM et al. Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J. Biol. Chem. 278(9), 7607–7616 (2003).
  • Dumont D, Noben JP, Raus J, Stinissen P, Robben J. Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients. Proteomics 4(7), 2117–2124 (2004).
  • Jager D, Taverna C, Zippelius A, Knuth A. Identification of tumor antigens as potential target antigens for immunotherapy by serological expression cloning. Cancer. Immunol. Immunother. 53(3), 144–147 (2004).
  • Guinn BA, Collin JF, Li G, Rees RC, Mufti GJ. Optimised SEREX technique for the identification of leukaemia-associated antigens. J. Immunol. Methods 264(1–2), 207–214 (2002).
  • Chen G, Zhang W, Cao X et al. Serological identification of immunogenic antigens in acute monocytic leukemia. Leuk. Res. 29(5), 503–509 (2005).
  • Segal NH, Blachere NE, Shiu HY et al. Antigens recognized by autologous antibodies of patients with soft tissue sarcoma. Cancer. Immun. 5, 4 (2005).
  • Koroleva EP, Lagarkova MA, Khlgatian SV et al. Serological analysis of the repertoire of human cancer antigens and autoantigens. Mol. Biol. 38(2), 191–195 (2004).
  • Bobrow MN, Harris TD, Shaughnessy KJ, Litt GJ. Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays. J. Immunol. Methods 125(1–2), 279–285 (1989).
  • Bobrow MN, Shaughnessy KJ, Litt GJ. Catalyzed reporter deposition, a novel method of signal amplification. II. Application to membrane immunoassays. J. Immunol. Methods 137(1), 103–112 (1991).
  • Graf R, Friedl P. Detection of immobilized proteins on nitrocellulose membranes using a biotinylation-dependent system. Anal. Biochem. 273(2), 291–297 (1999).
  • Hunyady B, Krempels K, Harta G, Mezey E. Immunohistochemical signal amplification by catalyzed reporter deposition and its application in double immunostaining. J. Histochem. Cytochem. 44(12), 1353–1362 (1996).
  • King G, Payne S, Walker F, Murray GI. A highly sensitive detection method for immunohistochemistry using biotinylated tyramine. J. Pathol. 183(2), 237–241 (1997).
  • Schweitzer B, Wiltshire S, Lambert J et al. Inaugural article: immunoassays with rolling circle DNA amplification: a versatile platform for ultrasensitive antigen detection. Proc. Natl Acad. Sci. USA 97(18), 10113–10119 (2000).
  • Stillman BA, Tonkinson JL. FAST slides: a novel surface for microarrays. Biotechniques 29(3), 630–635 (2000).
  • Tonkinson JL, Stillman BA. Nitrocellulose: a tried and true polymer finds utility as a post-genomic substrate. Front Biosci. 7, c1–c12 (2002).
  • Hanash S. Integrated global profiling of cancer. Nature Rev. Cancer 4(8), 638–644 (2004).
  • Zerhouni E. Medicine. The NIH roadmap. Science 302(5642), 63–72 (2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.